BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2 AND Treatment
4 results:

  • 1. Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: a multi-institutional retrospective analysis of KROG 16-01.
    Lee JH; Lee SW; Kim JR; Kim YS; Yoon MS; Jeong S; Kim JH; Lee JY; Eom KY; Jeong BK; Lee SH
    Gynecol Oncol; 2017 Dec; 147(3):577-584. PubMed ID: 29110878
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial.
    Van Damme P; Bouillette-Marussig M; Hens A; De Coster I; Depuydt C; Goubier A; Van Tendeloo V; Cools N; Goossens H; Hercend T; Timmerman B; Bissery MC
    Clin Cancer Res; 2016 Jul; 22(13):3238-48. PubMed ID: 27252412
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Successful en bloc venous resection with reconstruction and subsequent radiotherapy for 2 consecutive recurrences of intravenous leiomyoma--a case report.
    Zhang Y; Clark LH; Sheng X; Zhou C
    BMC Cancer; 2016 Jan; 16():6. PubMed ID: 26739818
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The influence of exogenous estrogen use on survival after diagnosis of endometrial cancer.
    Schwartzbaum JA; Hulka BS; Fowler WC; Kaufman DG; Hoberman D
    Am J Epidemiol; 1987 Nov; 126(5):851-60. PubMed ID: 3661533
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.